Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitisIkki Sakuma, Gerald I. Shulman, Traci E. LaMoia et al.|Proceedings of the National Academy of Sciences|2025Cited by 33
Imaging Mass Spectrometry Reveals Tumor Metabolic HeterogeneityYang Zhang, Matthew L. Steinhauser, Christelle Guillermier et al.|iScience|2020Cited by 32
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Gerald I. Shulman, Rafael Calais Gaspar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1